Assessing general side effects in clinical trials: reference data from the general population.
about
The pattern of complaints about Australian wind farms does not match the establishment and distribution of turbines: support for the psychogenic, 'communicated disease' hypothesis.Medication adherence in the general populationCatechol-O-methyltransferase Val158Met polymorphism is associated with somatosensory amplification and nocebo responsesEvaluating harm associated with anti-malarial drugs: a survey of methods used by clinical researchers to elicit, assess and record participant-reported adverse events and related data.How common are symptoms? Evidence from a New Zealand national telephone surveyPrediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines.Optimizing expectations to prevent side effects and enhance quality of life in breast cancer patients undergoing endocrine therapy: study protocol of a randomized controlled trialNonspecific adverse events in knee osteoarthritis clinical trials: a systematic review.To tell the truth, the whole truth, may do patients harm: the problem of the nocebo effect for informed consent.Inflammation-induced pain sensitization in men and women: does sex matter in experimental endotoxemia?Negative Stress Beliefs Predict Somatic Symptoms in Students Under Academic StressLearning to experience side effects after antidepressant intake - Results from a randomized, controlled, double-blind study.Explaining attitudes and adherence to antipsychotic medication: the development of a process model.Patients' Expectations Regarding Medical Treatment: A Critical Review of Concepts and Their AssessmentIs it best to expect the worst? Influence of patients' side-effect expectations on endocrine treatment outcome in a 2-year prospective clinical cohort study.Side effects can enhance treatment response through expectancy effects: an experimental analgesic randomized controlled trial.Adverse event assessment and reporting in trials of newer treatments for post-operative pain.What Makes You Feel Sick After Inflammation? Predictors of Acute and Persisting Physical Sickness Symptoms Induced by Experimental Endotoxemia.Initial development and testing of an instrument for patient self-assessment of adverse drug reactions.High perceived sensitivity to medicines is associated with higher medical care utilisation, increased symptom reporting and greater information-seeking about medication.Intensity of side effects of topical glaucoma medication and its influence on adherence behavior in patients with glaucomaWhat do women with breast cancer expect from their treatment? Correlates of negative treatment expectations about endocrine therapy.Effects of acute systemic inflammation on the interplay between sad mood and affective cognition.The placebo effect, sleep difficulty, and side effects: a balanced placebo model.Preserving learned immunosuppressive placebo response: perspectives for clinical application.Effect of single-dose dexamethasone on acute phase response following zoledronic acid: a randomized controlled trial.Preventing adverse events of chemotherapy by educating patients about the nocebo effect (RENNO study) - study protocol of a randomized controlled trial with gastrointestinal cancer patients
P2860
Q21089744-5B738A03-613B-4B13-BC8E-63ACE1AC1B9FQ28484426-67CDEE1A-EF42-4F0B-9D99-3F0FF0548ABDQ28542991-2B8FCECA-5259-4840-B551-901B3A94C877Q30667272-19382478-CFCB-49CC-9D25-F676152675B0Q33795804-7D7495A3-2879-4B4B-8CB7-72D21481BDECQ34131674-06F0024C-9B16-47AE-B887-3DB422C1AD31Q34991931-2D783A7E-D5B1-41F0-B5EB-3EDF6215CCC7Q35387933-91BEA60D-EF81-42D5-B594-9C9A58B830DCQ35961965-338E2B89-AE96-42FA-8A12-31B1A321F022Q36628292-A7388B55-3592-4893-B835-9A4733BA29E9Q37427403-9FD37B2D-50F5-43D7-9639-39EE5DC6AB25Q37578354-CB973211-CDEB-4D95-9E45-28129806E5C9Q37623597-162DD523-12E5-4985-8B7A-38CEF99BCD34Q37653909-123EDFA9-7FB3-4684-9FF7-4AC390B1740BQ38388524-DF696F49-33BB-4848-BA67-977BE240CF6BQ38759815-C1043F76-0558-440A-9FF6-E6C1C516A3FCQ38780020-F0063A24-4D89-46CB-B3A7-3B3EABC2A1E9Q39027868-6634F289-6E95-4C6C-AC0B-CB795CD90CD9Q40562472-AC04F17F-B72F-4A57-B098-C3B0857FAA35Q41103874-159862E2-C144-45D4-BBC9-4077FE1C2464Q41900804-D35B5B90-DFDA-49C4-BC37-4A66AA7BD8BEQ47332097-8B068207-3FB3-496D-A6F4-ABF2F4873005Q47682578-9E2910C9-B55E-4BB1-9B52-A49D214F5955Q48036466-08B5E915-81BB-4516-9280-049A4FA4EFADQ50672937-7EA48E10-5354-4148-B8C2-82D516620F67Q50875567-7A24DF4F-06A8-45DD-8653-A121E9B90F31Q58700971-ABD9A3FC-6238-4A2D-BE41-1142445832DD
P2860
Assessing general side effects in clinical trials: reference data from the general population.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Assessing general side effects ...... a from the general population.
@ast
Assessing general side effects ...... a from the general population.
@en
type
label
Assessing general side effects ...... a from the general population.
@ast
Assessing general side effects ...... a from the general population.
@en
prefLabel
Assessing general side effects ...... a from the general population.
@ast
Assessing general side effects ...... a from the general population.
@en
P2860
P50
P356
P1476
Assessing general side effects ...... a from the general population.
@en
P2093
Arthur J Barsky
P2860
P304
P356
10.1002/PDS.2067
P577
2010-11-08T00:00:00Z